HemaSphere (Jun 2022)
P439: ASSOCIATING EX VIVO DRUG SENSITIVITY WITH METABOLIC STATUS IDENTIFIES EFFECTIVE COMBINATION STRATEGIES IN ACUTE MYELOID LEUKEMIA
- D. A. Pereira-Martins,
- E. Griessinger,
- I. Weinhauser,
- J. L. Coelho-Silva,
- D. R. Silveira,
- L. Quek,
- A. Erdem,
- J. R. Hilberink,
- E. V. de Paula,
- S. T. Olalla Saad,
- E. Ammatuna,
- G. Huls,
- E. M. Rego,
- A. R. Lucena-Araujo,
- J. J. Schuringa
Affiliations
- D. A. Pereira-Martins
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- E. Griessinger
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- I. Weinhauser
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- J. L. Coelho-Silva
- 2 Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto
- D. R. Silveira
- 4 Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King’s College London, London, United Kingdom
- L. Quek
- 4 Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King’s College London, London, United Kingdom
- A. Erdem
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- J. R. Hilberink
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- E. V. de Paula
- 5 Hematology and BloodTransfusion Center, University of Campinas, Campinas, Brazil
- S. T. Olalla Saad
- 5 Hematology and BloodTransfusion Center, University of Campinas, Campinas, Brazil
- E. Ammatuna
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- G. Huls
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- E. M. Rego
- 2 Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto
- A. R. Lucena-Araujo
- 3 Department of Genetics, Federal University of Pernambuco, Recife, Brazil
- J. J. Schuringa
- 1 Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
- DOI
- https://doi.org/10.1097/01.HS9.0000844644.20199.83
- Journal volume & issue
-
Vol. 6
pp. 339 – 340
Abstract
No abstracts available.